Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-01

FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic ondansetron hydrochloride product from Eugia US LLC under ANDA 202600. This approval covers existing i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)